Invasive interval breast cancer rates after digital breast tomosynthesis plus synthesised mammography versus digital mammography screening (TOSYMA): 24-month follow-up of the multicentre, open-label, randomised, controlled, superiority trial
S. Weigel, H.W. Hense, V. Weyer-Elberich, J. Czwoydzinski, T. Decker, H. Kajüter, F. Oesterling, J. Heilmann, A. Stang, J. Kieschke, S. Wienbeck, O. Stephan, S. Baier, M. Krischke, A. Sommer, J. Gerß, W. Heindel, TOSYMA Screening Trial Study Group
Lancet Oncol. 2026 Oct 9:S1470-2045(26)00341-4. doi: 10.1016/S1470-2045(26)00341-4.
Digitale Brust-Tomosynthese und Befundung mit künstlicher Intelligenz
S. Weigel, P. Wunderlich, A. Sommer, J. Czwoydzinski, P.A.T. Baltzer, C.L.A. Dewald, H. Preibsch, S. Sauer, K.C. Siegmann-Luz, E. Wenkel, C. Wilpert, S.F.U. Blum
Rofo . 2026 Mar 4. doi: 10.1055/a-2796-5225.
False-Positive Recall and Biopsy Rates in Breast Cancer Screening: Insights from TOSYMA
B. Mesurolle, M. El Khoury
Radiology. 2025 Sep;316(3):e252367. doi: 10.1148/radiol.252367.
False-Positive Recall and False-Positive Biopsy Rates in Mammography Screening: A TOSYMA Trial Subanalysis.
S. Weigel, H.W. Hense, V. Weyer-Elberich, J. Gerß, W. Heindel; TOSYMA Screening Trial Group.
Radiology. 2025 Sep;316(3):e251014. doi: 10.1148/radiol.251014.
Radiologische Tumorzeichen von Mammakarzinomen im UICC-Stadium I: Subanalyse der randomisierten kontrollierten Studie TOSYMA
S. Weigel, H.W. Hense, V. Weyer-Elberich, J. Gerß, W. Heindel
Rofo. 2025 Mar 26. doi: 10.1055/a-2544-9085. Online ahead of print.
Radiation exposure and screening yield by digital breast tomosynthesis compared to mammography: results of the TOSYMA Trial breast density related
A. Sommer, S. Weigel, H.W. Hense, J. Gerß, V. Weyer-Elberich, L. Kerschke, E. Nekolla, H. Lenzen, W. Heindel
Eur Radiol. 2025 Jan;35(1):166-176. doi: 10.1007/s00330-024-10847-9. Epub 2024 Jul 16.